Rapid Screening for Exposure to "Non-Target" Pharmaceuticals from Wastewater Effluents by Combining HRMS-Based Suspect Screening and Exposure Modeling.

Active pharmaceutical ingredients (APIs) have raised considerable concern over the past decade due to their widespread detection in water resources and their potential to affect ecosystem health. This triggered many attempts to prioritize the large number of known APIs to target monitoring efforts and testing of fate and effects. However, so far, a comprehensive approach to screen for their presence in surface waters has been missing. Here, we explore a combination of an automated suspect screening approach based on liquid chromatography coupled to high-resolution mass spectrometry and a model-based prioritization using consumption data, readily predictable fate properties and a generic mass balance model for activated sludge treatment to comprehensively detect APIs with relevant exposure in wastewater treatment plant effluents. The procedure afforded the detection of 27 APIs that had not been covered in our previous target method, which included 119 parent APIs. The newly detected APIs included seven compounds with a high potential for bioaccumulation and persistence, and also three compounds that were suspected to stem from point sources rather than from consumption as medicines. Analytical suspect screening proved to be more selective than model-based prioritization, making it the method of choice for focusing analytical method development or fate and effect testing on those APIs most relevant to the aquatic environment. However, we found that state-of-the-practice exposure modeling used to predict potential high-exposure substances can be a useful complement to point toward oversights and known or suspected detection gaps in the analytical method, most of which were related to insufficient ionization.

[1]  Daniel J Caldwell,et al.  An integrated approach for prioritizing pharmaceuticals found in the environment for risk assessment, monitoring and advanced research. , 2014, Chemosphere.

[2]  Lubertus Bijlsma,et al.  Investigation of pharmaceuticals and illicit drugs in waters by liquid chromatography-high-resolution mass spectrometry , 2014 .

[3]  Philip H Howard,et al.  Identifying new persistent and bioaccumulative organics among chemicals in commerce II: pharmaceuticals. , 2011, Environmental science & technology.

[4]  M. Loos,et al.  Quantitative target and systematic non-target analysis of polar organic micro-pollutants along the river Rhine using high-resolution mass-spectrometry--Identification of unknown sources and compounds. , 2015, Water research.

[5]  Heinz Singer,et al.  Organic micropollutants in rivers downstream of the megacity Beijing: sources and mass fluxes in a large-scale wastewater irrigation system. , 2012, Environmental science & technology.

[6]  D. Lapworth,et al.  Emerging organic contaminants in groundwater: A review of sources, fate and occurrence. , 2012, Environmental pollution.

[7]  Heinz Singer,et al.  High-throughput identification of microbial transformation products of organic micropollutants. , 2010, Environmental science & technology.

[8]  Emma L. Schymanski,et al.  Strategies to characterize polar organic contamination in wastewater: exploring the capability of high resolution mass spectrometry. , 2014, Environmental science & technology.

[9]  S. Jørgensen,et al.  Occurrence, fate and effects of pharmaceutical substances in the environment--a review. , 1998, Chemosphere.

[10]  Jeanne Garric,et al.  Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation. , 2008, Toxicology letters.

[11]  F Sacher,et al.  Development of a common priority list of pharmaceuticals relevant for the water cycle. , 2009, Water science and technology : a journal of the International Association on Water Pollution Research.

[12]  C Rudén,et al.  Prioritising pharmaceuticals for environmental risk assessment: Towards adequate and feasible first-tier selection. , 2012, The Science of the total environment.

[13]  Hans Sanderson,et al.  Ranking and prioritization of environmental risks of pharmaceuticals in surface waters. , 2004, Regulatory toxicology and pharmacology : RTP.

[14]  B. Escher,et al.  Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes. , 2007, Environmental science & technology.

[15]  J. Lazorchak,et al.  Risks to aquatic organisms posed by human pharmaceutical use. , 2008, The Science of the total environment.

[16]  Kelly R Munkittrick,et al.  Prioritizing contaminants of emerging concern for ecological screening assessments , 2011, Environmental toxicology and chemistry.

[17]  Arun Kumar,et al.  Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: a proposed ranking system. , 2010, The Science of the total environment.

[18]  Mira Petrovic,et al.  Recent trends in the liquid chromatography-mass spectrometry analysis of organic contaminants in environmental samples. , 2010, Journal of chromatography. A.

[19]  Nathalie Chèvre,et al.  Occurrence and fate of micropollutants in the Vidy Bay of Lake Geneva, Switzerland. Part I: Priority list for environmental risk assessment of pharmaceuticals , 2010, Environmental toxicology and chemistry.

[20]  K. Demeestere,et al.  Balancing the false negative and positive rates in suspect screening with high-resolution Orbitrap mass spectrometry using multivariate statistics. , 2015, Analytical chemistry.

[21]  J. Fick,et al.  A Multivariate Chemical Similarity Approach to Search for Drugs of Potential Environmental Concern , 2011, J. Chem. Inf. Model..

[22]  K. Fent,et al.  Highly active human pharmaceuticals in aquatic systems: A concept for their identification based on their mode of action. , 2010, Aquatic toxicology.

[23]  Emma L. Schymanski,et al.  Identifying small molecules via high resolution mass spectrometry: communicating confidence. , 2014, Environmental science & technology.

[24]  René P Schwarzenbach,et al.  Identification of transformation products of organic contaminants in natural waters by computer-aided prediction and high-resolution mass spectrometry. , 2009, Environmental science & technology.

[25]  Kristof Demeestere,et al.  Trends in liquid chromatography coupled to high-resolution mass spectrometry for multi-residue analysis of organic micropollutants in aquatic environments , 2015 .

[26]  Å. Wennmalm,et al.  Public Health Care Management of Water Pollution with Pharmaceuticals: Environmental Classification and Analysis of Pharmaceutical Residues in Sewage Water , 2005 .

[27]  D Fatta-Kassinos,et al.  Urban wastewater treatment plants as hotspots for the release of antibiotics in the environment: a review. , 2013, Water research.

[28]  Colin R. Janssen,et al.  Coupled chromatographic and mass-spectrometric techniques for the analysis of emerging pollutants in the aquatic environment , 2012 .

[29]  Martin Krauss,et al.  LC–high resolution MS in environmental analysis: from target screening to the identification of unknowns , 2010, Analytical and bioanalytical chemistry.

[30]  H Kroiss,et al.  Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. , 2005, Water research.

[31]  A. Mulchandani,et al.  Phylogenetic diversity and metabolic potential of activated sludge microbial communities in full-scale wastewater treatment plants. , 2011, Environmental science & technology.

[32]  Bryan W Brooks,et al.  Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals. , 2010, Toxicology letters.

[33]  M. Miller Agency , 2010 .

[34]  J. Garric,et al.  Exposure Assessment of Pharmaceuticals and Their Metabolites in the Aquatic Environment: Application to the French Situation and Preliminary Prioritization , 2008 .

[35]  J. Cook,et al.  A Theoretical Model for Utilizing Mammalian Pharmacology and Safety Data to Prioritize Potential Impacts of Human Pharmaceuticals to Fish , 2003 .

[36]  D. Holdway,et al.  Pharmaceuticals and personal care products: A critical review of the impacts on fish reproduction , 2015, Critical reviews in toxicology.

[37]  Francesco Corona,et al.  Accelerated isotope fine structure calculation using pruned transition trees. , 2015, Analytical chemistry.

[38]  Ludek Blaha,et al.  Pan-European survey on the occurrence of selected polar organic persistent pollutants in ground water. , 2010, Water research.

[39]  Heinz Singer,et al.  Alleviating the reference standard dilemma using a systematic exact mass suspect screening approach with liquid chromatography-high resolution mass spectrometry. , 2013, Analytical chemistry.

[40]  J. Dewulf,et al.  Fluoroquinolone antibiotics: an emerging class of environmental micropollutants. , 2014, The Science of the total environment.

[41]  Thomas Letzel,et al.  Non-target screening with high-resolution mass spectrometry: critical review using a collaborative trial on water analysis , 2015, Analytical and Bioanalytical Chemistry.

[42]  Mark A J Huijbregts,et al.  Ranking potential impacts of priority and emerging pollutants in urban wastewater through life cycle impact assessment. , 2008, Chemosphere.

[43]  A. Boxall,et al.  Uptake of veterinary medicines from soils into plants. , 2006, Journal of agricultural and food chemistry.

[44]  B. Kasprzyk-Hordern,et al.  A review on emerging contaminants in wastewaters and the environment: current knowledge, understudied areas and recommendations for future monitoring. , 2015, Water research.

[45]  M. Honti,et al.  Micropollutant biotransformation kinetics associate with WWTP process parameters and microbial community characteristics. , 2012, Environmental science & technology.

[46]  Y. Picó,et al.  Advances in the analysis of legal and illegal drugs in the aquatic environment , 2013 .

[47]  K. Fent,et al.  Ecotoxicology of human pharmaceuticals. , 2006, Aquatic toxicology.

[48]  E. Cooper,et al.  Preliminary risk assessment database and risk ranking of pharmaceuticals in the environment. , 2008, The Science of the total environment.